Agnieszka et al [33] reported that in a small sample of perimenopausal women with hypertension (n=152) and normotensive controls (n=40), IGFBP2 levels were inversely correlated with hypertension and metabolic syndrome. Here, IGFBP2 is linked to hypertensive disorder.